ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 733 • 2019 ACR/ARP Annual Meeting

    Vonoprazan, a Novel Potassium-competitive Acid Blocker, for Treatment of Proton Pump Inhibitor-resistant Reflux Esophagitis in Patients with Systemic Sclerosis

    Yuichiro Shirai1, Noriyuki Kawami 2, Katsuhiko Iwakiri 2 and Masataka Kuwana 1, 1Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, Bunkyo-ku, Tokyo, Japan, 2Department of Gastroenterology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, Bunkyo-ku, Tokyo, Japan

    Background/Purpose: Esophageal involvement is one of the most frequent organ manifestations in patients with systemic sclerosis (SSc). Gastroesophageal reflux disease (GERD) is associated with reflux…
  • Abstract Number: 734 • 2019 ACR/ARP Annual Meeting

    Risk Assessment in Connective Tissue Disease Associated Pulmonary Arterial Hypertension

    Yuichiro Shirai1, Hidekata Yasuoka 2, Yuichi Tamura 3 and Masataka Kuwana 1, 1Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, Bunkyo-ku, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine, Aichi, Japan, Toyoake, Aichi, Japan, 3Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan, Tokyo, Japan

    Background/Purpose: Pulmonary arterial hypertension (PAH) still holds a poor prognosis in patients with connective tissue diseases (CTD), especially those with systemic sclerosis (SSc). A variety…
  • Abstract Number: 735 • 2019 ACR/ARP Annual Meeting

    The Relationship Between Gastrointestinal Symptoms and Severity and Whole Gut Transit in Patients with Systemic Sclerosis

    Zsuzsanna McMahan* 1, Ana Tucker*2, Jamie Perin 3, Jay Pasricha 4, Harvey Ziessman 5, Antony Rosen 1 and Frederick Wigley 1, 1Johns Hopkins University, Division of Rheumatology, Baltimore, 2Johns Hopkins Bayview Medical Center, Baltimore, MD, 3Johns Hopkins University School of Public Health, Department of International Health, Baltimore, 4Johns Hopkins University, Division of Gastroenterology, Baltimore, 5Johns Hopkins University, Division of Radiology, Baltimore

    Background/Purpose: The gastrointestinal (GI) tract is the most commonly affected internal organ system in systemic sclerosis (SSc), resulting in significant morbidity and mortality. Several studies…
  • Abstract Number: 736 • 2019 ACR/ARP Annual Meeting

    Reduced Circulating Levels of Inorganic Pyrophosphate Are Associated with Ectopic Calcification in Scleroderma Spectrum Disorders

    Vivien Hsu1, Naomi Schlesinger 2, Qiaoli Li 3 and John Varga 4, 1Rutgers- RWJ Medical School, SOUTH PLAINFIELD, NJ, 2Rutgers Health- RWJ Medical School, New Brunswick, NJ, 3Thomas Jefferson University, Philadelphia, PA, 4Northwestern University, Chicago,, IL

    Background/Purpose: Calcinosis cutis due to ectopic mineralization is a common and disabling complication of systemic sclerosis (SSc) that has poorly understood pathogenesis and no effective…
  • Abstract Number: 737 • 2019 ACR/ARP Annual Meeting

    The MUC5B Promoter Variant Does Not Predict Outcomes in Systemic Sclerosis-related Interstitial Lung Disease

    Elizabeth Volkmann1, Donald Tashkin 2, Michael Roth 3, Ning Li 2, Grace Kim 2, Jonathan Goldin 2, Maureen Mayes 4, Julio Charles 5, Philip Clements 2, Daniel Furst 6, Dinesh Khanna 7, Robert Elashoff 2 and Shervin Assassi 4, 1University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, 2University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, 3University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 4Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, Texas, USA, Houston, TX, 5University of Texas, Houston, Houston, 6University of California, Los Angeles, CA, 7Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA, Ann Arbor

    Background/Purpose: Interstitial lung disease (ILD) affects the majority of patients with systemic sclerosis (SSc). The disease course of ILD varies among SSc patients and no…
  • Abstract Number: 738 • 2019 ACR/ARP Annual Meeting

    Systemic Sclerosis Myocarditis Has Unique Clinical, Histological and Prognostic Features: Comparative Analysis Between Patients with Endomyocardial Biopsy-proven Myocarditis

    Giacomo De Luca1, Silvia Bosello 2, Corrado Campochiaro 1, Silvia Sartorelli 3, Giovanni Peretto 4, Simone Sala 5, Giovanni Canestrari 2, Gaetano Thiene 6, Cristina Basso 6, Paolo Della Bella 4, Elisa Gremese 7 and Lorenzo Dagna 1, 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy, 2Rheumathology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 3Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy, 4Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy, 5Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Mialn, Italy, 6Cardiovascular Pathology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University and Hospital of Padua, Padua, Italy, 7Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Background/Purpose: Myocarditis is a life-threatening inflammatory disease increasingly reported in Systemic Sclerosis(SSc); the histological, clinical and prognostic features of SSc-myocardits have not been elucidated yet.…
  • Abstract Number: 739 • 2019 ACR/ARP Annual Meeting

    Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities?

    Mislav Radic1, Rebecca Overbury 2 and Tracy Frech 3, 1University Hospital Split, Split, Croatia, 2University of Utah, Departments of Pediatrics and Internal Medicine, Division of Rheumatology, Salt Lake City, UT, 3Division of Rheumatology, University of Utah and Salt Lake VAMC, Salt Lake City, UT

    Background/Purpose: The fingers have specialized structural and functional features for thermoregulation, and are the most common areas of Raynaud’s phenomenon (RP) in systemic sclerosis (SSc).…
  • Abstract Number: 740 • 2019 ACR/ARP Annual Meeting

    Rituximab Rescue Therapy in Patients with Systemic Sclerosis or Other Connective Tissue Diseases and Refractory Interstitial Lung Disease

    Magdalena Benad 1, Dirk Koschel 1, Kristine Herrmann 1, Kristin Wiefel 1, Alexander Kleymann 1 and Martin Aringer2, 1University Medical Center and Faculty of Medicine TU Dresden, Dresden, Germany, 2Division of Rheumatology, Department of Medicine III, University Medical Center & Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany, Dresden, Germany

    Background/Purpose: Interstitial lung disease (ILD) is a common and life-threatening organ manifestation of patients with various connective tissue diseases (CTDs), and with systemic sclerosis and…
  • Abstract Number: 741 • 2019 ACR/ARP Annual Meeting

    Vascular Damage Is Less Present in an Early Inception Cohort in Takayasu’s Arteritis

    Fatma Alibaz-Oner1, 1Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey

    Background/Purpose: There is only retrospective and very limited data for the long term prognosis of Takayasu's Arteritis (TAK), a rare large-vessel vasculitis. In this study,…
  • Abstract Number: 742 • 2019 ACR/ARP Annual Meeting

    Polymyalgia Rheumatica: New Therapeutic Strategy Based on Low Dose Metrotexate Plus Local Infiltration with Corticosteroids

    Miriam Retuerto1, Pilar Fernández-Dapica 2, Patricia Lavilla 3, Fernando Lozano 3, M. Eva Vallejo 4 and José Luis Pablos 5, 1Rheumatology Department. Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 2Hospital universitario 12 de octubre, Instituto de investigacion hospital 12 de octubre (i+12), Madrid, Spain, 3Rheumatology Department. Hospital universitario 12 de octubre, Instituto de investigacion hospital 12 de octubre (i+12), Madrid, Spain, 4Facultad de CC. EE y Empresariales, Universidad de Leon, Leon, Spain, 5Rheumatology Department. Hospital universitario 12 de octubre, Instituto de investigacion hospital 12 de octubre (i+12), Universidad Complutense de Madrid, Madrid, Spain

    Background/Purpose: Polymyalgia rheumatic (PMR) is a common rheumatic inflammatory disease in the elderly. Glucocorticoids (GC) are the therapeutic mainstay in PMR but induce significant toxicity…
  • Abstract Number: 743 • 2019 ACR/ARP Annual Meeting

    Association Between Acute-phase Reactants, interleukin-6(IL6), Tumor Necrosis Factor-a(TNFa) and Disease Activity in Takayasu’s Arteritis During Follow-up with Repeated Evaluation of Vascular Imaging Manifestations

    JIng LI1, Yunjiao Yang 1, Yanhong WANG 2, Jiuliang Zhao 1, Mengtao Li 3, Xinping Tian 1 and Xiaofeng Zeng 1, 1Peking Union Medical College Hospital, Beijing, China (People's Republic), 2Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Beijing, China (People's Republic), 3Dept. of Rheumatology, Peking Union Medical College Hospital (West Campus), Beijing, China, Beijing, China (People's Republic)

    Background/Purpose: To investigate the laboratory indicators of disease activity during follow-up of Takayasu’s arteritis(TAK).Methods: Electronic data of 588 patients with TAK enrolled in the Chinese…
  • Abstract Number: 744 • 2019 ACR/ARP Annual Meeting

    Are Hematologic Indexes Helpful in the Diagnosis and Prognosis of Polymyalgia Rheumatica?

    María de la Torre1 and Cecilia Pisoni 1, 1Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: Recently, the use of hematologic indexes as markers of systemic inflammation has been reported in oncological, cardiovascular and rheumatic diseases. Only 2 studies evaluated…
  • Abstract Number: 745 • 2019 ACR/ARP Annual Meeting

    Cardiac Involvements Are Related to Poor Prognosis in Patients with Takayasu’s Arteritis in China

    Yujiao Wang1, Lili Ma 1, Yan Yan 2, Ying Sun 3, Yongshi Wang 4, Xiaomin Dai 1, Zongfei Ji 5, Lingying Ma 1, Huiyong Chen 3 and Lindi Jiang 1, 1Zhongshan Hospital, Fudan University, Shanghai, China (People's Republic), 2Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, China (People's Republic), 3Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, 4Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, 5Department of Rheumatology, Zhongshan hospital, Fudan University, Shanghai, China (People's Republic)

    Background/Purpose: Heart involvements are closely associated with prognosis in patients with Takayasu’s arteritis (TA). This study was aimed to assess the long-term adverse outcomes of…
  • Abstract Number: 746 • 2019 ACR/ARP Annual Meeting

    Childhood-Onset Takayasu’s Arteritis (TAK) Is Clinically More Active, However Has Similar Cumulative Damage Compared to Adult-Onset TAK

    Murat Karabacak1, Sema Kaymaz-Tahra 2, Sezgin Sahin 3, Mehmet Yıldız 4, Amra Adrovic 5, Kenan Barut 6, Haner Direskeneli 7, Ozgur Kasapcopur 8 and Fatma Alibaz-Oner 1, 1Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey, 2Marmara University School of Medicine, Division of Rheumatology, Istanbul, Istanbul, Turkey, 3Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey, Istanbul, Istanbul, Turkey, 4Department of Pediatric Rheumatology, Istanbul University Cerrahpasa, Istanbul, Istanbul, Turkey, 5Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey, Istanbul, Turkey, 6Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey, İstanbul, Istanbul, Turkey, 7Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey, 8Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa, Istanbul, Turkey, Istanbul, Turkey

    Background/Purpose: Childhood-onset Takayasu’s Arteritis (TAK) may differ in presentation, clinical manifestations and treatment, as previously shown1. We aimed to compare the clinical manifestations, vascular involvement…
  • Abstract Number: 747 • 2019 ACR/ARP Annual Meeting

    Detrimental Factors Affecting the First-year Clinical Response in Korean Patients with Polymyalgia Rheumatica

    Yoon-Jeong Oh 1, Seung Min Jung 2, Byoong Yong Choi 3 and Kichul Shin4, 1Kanwon National University Hospital, Chuncheon, Republic of Korea, 2Yonsei university college of medicine, severance hospital, Seodaemun-gu, Republic of Korea, 3Seoul Medical Center, Seoul, Republic of Korea, 4Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea., seoul, Republic of Korea

    Background/Purpose: Polymyalgia rheumatica (PMR) is a chronic inflammatory disease in which patients respond well to glucocorticoids (GCs). However, a number of patients experience a flare…
  • « Previous Page
  • 1
  • …
  • 987
  • 988
  • 989
  • 990
  • 991
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology